Switching from semaglutide to zovaglutide for weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether switching from an existing GLP-1 weight-loss medication (like semaglutide) to a new medicine called zovaglutide is safe and tolerable for adults with obesity. It may help you maintain or improve weight loss with a potentially different medication option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your body mass index (BMI) is 28 or higher (this means you have obesity).
- Your weight has not changed by more than 5% in the last 3 months from diet and exercise alone.
- You have not been diagnosed with diabetes, and your blood sugar levels are not in the diabetes range.
- You have no history of pancreatitis or pancreatic injury.
- You have no personal or family history of medullary thyroid cancer or MEN2 (a rare genetic condition).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called zenagamtide for adults with overweight or obesity, with or without type 2 diabetes, who are currently taking semaglutide. The goal is to see how well people tolerate switching from semaglutide to the new treatment.
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.